Cargando…
Current pharmacological treatments for COVID‐19: What's next?
Since December 2019 SARS‐Cov‐2 was found responsible for the disease COVID‐19, which has spread worldwide. No specific therapies/vaccines are yet available for the treatment of COVID‐19. Drug repositioning may offer a strategy and a number of drugs have been repurposed, including lopinavir/ritonavir...
Autores principales: | Scavone, Cristina, Brusco, Simona, Bertini, Michele, Sportiello, Liberata, Rafaniello, Concetta, Zoccoli, Alice, Berrino, Liberato, Racagni, Giorgio, Rossi, Francesco, Capuano, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264618/ https://www.ncbi.nlm.nih.gov/pubmed/32329520 http://dx.doi.org/10.1111/bph.15072 |
Ejemplares similares
-
Therapeutic strategies to fight COVID‐19: Which is the status artis?
por: Scavone, Cristina, et al.
Publicado: (2021) -
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2020) -
Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
por: Scavone, Cristina, et al.
Publicado: (2018) -
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
por: Mascolo, Annamaria, et al.
Publicado: (2020) -
Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2019)